N.H. Code Admin. R. He-P 311.07
For the purposes of immunity, actions taken pursuant to this section shall be considered an emergency management function under RSA 21-P:41, I.
Source. #13304, EMERGENCY RULE, eff 12-10-21; ss by #13380-A, eff 5-25-22
Appendix A
Documents Incorporated by Reference
Rule
Title
Publisher, How to Obtain, Cost
He-P 301.02(e)(2)
NH Local Implementation Guide for Electronic Laboratory Reporting using HL7, 2.5.1, 7/31/2014.
Available as an on-line document free of charge at www.dhhs.nh.gov/dphs/bphsi/documents/elrguide
He-P 301.03(i)(1)
NH Local Implementation Guide for Syndromic Surveillance Reporting, Version 1.07, 2/15/15.
Available as an on-line document free of charge at www.nh.gov/dphs.
He-P 301.04
Healthcare Infection Control Practices Advisory Committee 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, June 2007.
Available as an on-line document free of charge at www.cdc.gov/hicpac.
He-P 301.04
Healthcare Infection Control Practices Advisory Committee, Management of Multi-drug Resistant Organisms in Healthcare Settings, HICPAC Advisory Committee. October 2006.
Available as an on-line document free of charge at www.cdc.gov/hicpac/mdroGuidelines2006.
He-P 301.11(c)(5)
US Department of Health and Human Services Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents.
Available free of charge at: https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.
He-P 301.14
Recommended Immunization Schedules for Persons Aged 0-18 years- US 2016 by Centers for Disease Control and Prevention (CDC) and as approved by the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP).
Available on line free of charge at www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.
He-P 304.01(m)
“Chapter III, Standards for Tumor Inclusion and Reportability” Table 2. “NAACCR Layout Version 15: “Comparison of Reportable Cancers” “NPCR Requirements.” (Thornton ML, (ed)). “Standards for Cancer Registry Operations”/Volume II: “Data Standards and Data Dictionary, Record Layout” Version 15, 19th ed. (Posted October 2014, Revised February 27, 2015), Springfield, Ill.: North American Association of Central Cancer Registries, (NAACCR).
Available online at no cost at www.naaccr.org.
He-M 304.02(b) and (g)
North American Association of Central Cancer Registries (NAACCR), “Standard for Cancer Registries, Volume II”/“Data Standard and Data Dictionary”, 19th (ed.), “Record Layout Version 15”, Implementation: January 1, 2015, Edited by Monica Thornton, Revised February 2015.
Available online at no cost at www.naaccr.org.
He-M 304.02(b) and (g)
“Standards for Cancer Registries” Volume V: “Pathology Laboratory Electronic Reporting, Version 4.0.”Klein Wt., Havener L. (eds.) Springfield (IL); North American Association of Central Cancer Registries, Inc., April, 2011.
Available online at no cost at www.naaccr.org.
He-M 304.02(b) and (g)
National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention and Control, “Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries” HL7 Clinical Document Architecture (CDA) Release 1.1 (March, 2014).
Available online at no cost at http://cdc.gov/cancer/npcr/meaningful_use.html.
He-M 304.07(d)(7)
Surveillance, Epidemiology and End Results Program (SEER) “Case Finding List, Current List”, ICD-10-CM-(FY 2015-October 1, 2015-September 30, 2016.
Available online at no cost at http://seer.cancer.gov/tools/casefinding.
He-P 307.05(b)
Centers for Disease Control and Prevention’s, “Core Data Elements for Immunization Information Systems, listed in the functional standards document and in Appendix B in HL7 Version 2.5.1: Implementation Guide for Immunization Messaging Release 1.5” (October 2018)
Publisher: Centers for Disease Control and Prevention
Cost: Free of Charge
The incorporated document is available at:
https://www.cdc.gov/vaccines/programs/iis/technical-guidance/hl7.html; or
He-P 309.03(a)
United States Centers for Disease Control and Prevention, National Healthcare Safety Network’s, “Catheter-Associated Urinary Tract Infection (CAUTI) Event” (January 2019 Edition)
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
http://www.cdc.gov/nhsn/PDFs/pscManual/7pscCAUTIcurrent.pdf
He-P 309.04(a)
United States Centers for Disease Control and Prevention, National Healthcare Safety Network’s, “Central Line Bloodstream Infection (CLABSI) Event” (January 2019 Edition)
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC_CLABScurrent.pdf
He-P 309.05(b)
United States Centers for Disease Control and Prevention, National Healthcare Safety Network’s, “Central Line Insertion Practices (CLIP) Adherence Monitoring” (January 2019 Edition)
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
http://www.cdc.gov/nhsn/PDFs/pscManual/5psc_CLIPcurrent.pdf
He-P 309.06(a)
United States Center for Disease Control and Prevention, National Healthcare Safety Network’s, “Surgical Site Infection (SSI) Event” (January 2019 Edition).
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
http://www.cdc.gov/nhsn/PDFs/pscManual/9pscSSIcurrent.pdf
He-P 309.07(a)
United States Center for Disease Control and Prevention, National Healthcare Safety Network’s, “Multidrug-Resistant Organism and Clostridiodes difficile Infection (MDRO/CDI) Module” (January 2019 Edition).
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf
He-P 309.08(b)(1)
United States Center for Disease Control and Prevention, National Healthcare Safety Network’s, “Antimicrobial Use and Resistance (AUR) Module” (January 2019 Edition)
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
https://www.cdc.gov/nhsn/pdfs/pscmanual/11pscaurcurrent.pdf
He-P 309.09(a); He-P 309.10(a); and He-P 309.11(e)
United States Center for Disease Control and Prevention, National Healthcare Safety Network’s, “End Stage Renal Dialysis (ESRD) Event” (February 2018 Edition)
Publisher: United States Center for Disease Control and Prevention
Cost: Free to the Public
The incorporated document is available at:
http://www.cdc.gov/nhsn/pdfs/pscmanual/8pscdialysiseventcurrent.pdf
He-P 309.11(j)
World Health Organization’s “International Classification of Diseases” (11th Revision)
Publisher: World Health Organization
Cost: Free to the Public
The incorporated document is available at: https://icd.who.int/en
APPENDIX B
RULE
RSA/FEDERAL CITATION
He-P 301.01
RSA 141-C:2
He-P 301.02
RSA 141-C:6, I , RSA 141-C:7; RSA 141-C:8
He-P 301.03
RSA 141-C:6, I; RSA 141-C:7
He-P 301.04
RSA 141-C:11-15
He-P 301.05
RSA 141-C:11-15
He-P 301.06
RSA 132:6; RSA 132:10-b
He-P 301.07
RSA 141-C:3, RSA 141-C:9
He-P 301.08
RSA 141-C:10
He-P 301.09
RSA 141-C:16-a
He-P 301.10
RSA 141-C:17; RSA 141-C:17-a
He-P 301.11
RSA 141-C:2, IV, RSA 141-C:3, III
He-P 301.11(b), (c) intro., (c)(3), (c)(4), (g) intro., (g)(1) intro., and (g)(1)d.
RSA 141-C:2, VI, RSA 141-C:3, III, RSA 141-C:4, X.,
RSA 141-C:15, IV
He-P 301.12
RSA 141-C:11, RSA 141-C:12
He-P 301.13
RSA 141-C:20-a through RSA 141-C:20-e
He-P 301.14
RSA 141C:20-a thru e
He-P 301.15
RSA 141C:20-a thru e
He-P 301.16
RSA 141-C:6, XI
He-P 301.17(c) intro., (c)(4), (e), (h) intro., (h)(3), (h)(5) intro., (h)(5)e., and (o)
RSA 141-C:15, III
He-P 304.01
RSA 141-B:2
He-P 304.02
RSA 141-B:7; RSA 141-B:8, II, RSA 141-B:10
He-P 304.03
RSA 141-B:7; RSA 141-B:8, II, RSA 141-B:10
He-P 304.04
RSA 141-B:7; RSA 141-B:8, II, RSA 141-B:10
He-P 304.05
RSA 141-B:7; RSA 141-B:8, II, RSA 141-B:10
He-P 304.06
RSA 141-B:7; RSA 141-B:8, II, RSA 141-B:10
He-P 304.07
RSA 141-B:8, III; RSA 141-B:8, IV; RSA 141-B:9,
42 USC 280e(c)(2)(D)(viii)
He-P 304.08
RSA-141-B:8, III; RSA 141-B:9; 45 CFR 164,
45 CFR164.502, 45 CFR 164.506, 45 CFR 164.512
He-P 304.09
RSA 141-B:8, III, RSA 141-B:9
He-P 304.10
RSA 141-B:8, III, RSA 141-B:9
He-P-305.01
RSA 541-A:7
He-P 305.02
RSA 151:2
He-P 305.03
RSA 141-F:6
He-P 305.04
RSA 141-F:5 through F:7
He-P 305.05
RSA 141-F:5, IV
He-P 305.06
RSA 141-F:7
He-P 307.01 – H-P 307.06
RSA 141-C:20-f
He-P 307.07
RSA 141-C:20-f, III; RSA 141-C:20-f, IIII-a
He-P 307.08 -307.11
He-P 307.01 – 307.06; RSA 141-C:20-f
He-P 308.01
RSA 141-C:25, I, RSA 430:13
He-P 308.02
RSA 141-C:24, RSA 141-C:25, IV, as amended by Chapter Law 73 of the 2008 Session
He-P 308.03
RSA 141-C:24, RSA 430:13
He-P 308.04
RSA 141-C:25, III, RSA 141-C:25, IV
He-P 308.05
RSA 141-C:25, III, RSA 141-C:25, IV, RSA 141-C:25, V
He-P 308.06
RSA 141-C:25, III, (b)
He-P 309.01
RSA 151:32
He-P 309.02
RSA 151:33; RSA 151:35
He-P 309.03
RSA 151:33: I, II(a)(2), III, IV, V; RSA 151:35
He-P 309.04
RSA 151:33: I, II(a)(1), IV, V; RSA 151:35
He-P 309.05
RSA 151:33: I, II(b)(1), IV, V; RSA 151:35
He-P 309.06
RSA 151:33: I, II(a)(3), II-a(a), IV, V; RSA 151:35
He-P 309.07
RSA 151:33: I, III, IV; RSA 151:35
He-P 309.08
RSA 151:33:I, III, IV; RSA 151:35
He-P 309.09
RSA 151:33, II-b (b), IV, RSA 151:35
He-P 309.10
RSA 151:33, I, II-a (b), IV and, V, RSA 151:35
He-P 309.11
RSA 151:33, I, II-a (b), IV, V, RSA 151:35
He-P 309.12
RSA 151-:33, I, II-a (c) IV, V, RSA 151:35
He-P 309.13
RSA 151:36
He-P 311.01
RSA 141-C:26
He-P 311.02
RSA 141-C:26
He-P 311.03
RSA 141-C:26
He-P 311.04
RSA 141-C:26
He-P 311.05
RSA 141-C:26
He-P 311.06
RSA 141-C:26
He-P 311.07
RSA 141-C:26